pubmed-article:15890415 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15890415 | lifeskim:mentions | umls-concept:C0019682 | lld:lifeskim |
pubmed-article:15890415 | lifeskim:mentions | umls-concept:C0019699 | lld:lifeskim |
pubmed-article:15890415 | lifeskim:mentions | umls-concept:C0521026 | lld:lifeskim |
pubmed-article:15890415 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:15890415 | lifeskim:mentions | umls-concept:C0028621 | lld:lifeskim |
pubmed-article:15890415 | lifeskim:mentions | umls-concept:C0079866 | lld:lifeskim |
pubmed-article:15890415 | lifeskim:mentions | umls-concept:C1707689 | lld:lifeskim |
pubmed-article:15890415 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:15890415 | pubmed:dateCreated | 2005-6-13 | lld:pubmed |
pubmed-article:15890415 | pubmed:abstractText | We report the activities of a novel nucleoside analog against HIV. This nucleoside (KP-1212) is not a chain terminator but exerts its antiviral effects via mutagenesis of the viral genome. Serial passaging of HIV in the presence of KP-1212 causes an increase in the mutation rate of the virus leading to viral ablation. HIV strains resistant to KP-1212 have not yet been isolated. Quite to the contrary, virus treated with KP-1212 exhibited an increased sensitivity not only to KP-1212 but also to another nucleoside reverse transcriptase inhibitor (NRTI), zidovudine. HIV strains resistant to other NRTIs (e.g. zidovudine, lamivudine, stavudine, abacavir, etc.) exhibited no cross-resistance towards KP-1212. Multiple assays confirmed that KP-1212 has a favorable (low) genotoxicity profile when compared to some approved antiviral nucleosides. In addition, KP-1212 is not toxic to mitochondria nor does it exhibit any inhibitory effects on mitochondrial DNA synthesis. | lld:pubmed |
pubmed-article:15890415 | pubmed:language | eng | lld:pubmed |
pubmed-article:15890415 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15890415 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15890415 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15890415 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15890415 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15890415 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15890415 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15890415 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15890415 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15890415 | pubmed:month | Jul | lld:pubmed |
pubmed-article:15890415 | pubmed:issn | 0166-3542 | lld:pubmed |
pubmed-article:15890415 | pubmed:author | pubmed-author:DaifukuRichar... | lld:pubmed |
pubmed-article:15890415 | pubmed:author | pubmed-author:HarrisKevin... | lld:pubmed |
pubmed-article:15890415 | pubmed:author | pubmed-author:BrabantWillia... | lld:pubmed |
pubmed-article:15890415 | pubmed:author | pubmed-author:StyrchakSheil... | lld:pubmed |
pubmed-article:15890415 | pubmed:author | pubmed-author:GallAlexander... | lld:pubmed |
pubmed-article:15890415 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15890415 | pubmed:volume | 67 | lld:pubmed |
pubmed-article:15890415 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15890415 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15890415 | pubmed:pagination | 1-9 | lld:pubmed |
pubmed-article:15890415 | pubmed:dateRevised | 2007-9-12 | lld:pubmed |
pubmed-article:15890415 | pubmed:meshHeading | pubmed-meshheading:15890415... | lld:pubmed |
pubmed-article:15890415 | pubmed:meshHeading | pubmed-meshheading:15890415... | lld:pubmed |
pubmed-article:15890415 | pubmed:meshHeading | pubmed-meshheading:15890415... | lld:pubmed |
pubmed-article:15890415 | pubmed:meshHeading | pubmed-meshheading:15890415... | lld:pubmed |
pubmed-article:15890415 | pubmed:meshHeading | pubmed-meshheading:15890415... | lld:pubmed |
pubmed-article:15890415 | pubmed:meshHeading | pubmed-meshheading:15890415... | lld:pubmed |
pubmed-article:15890415 | pubmed:meshHeading | pubmed-meshheading:15890415... | lld:pubmed |
pubmed-article:15890415 | pubmed:meshHeading | pubmed-meshheading:15890415... | lld:pubmed |
pubmed-article:15890415 | pubmed:meshHeading | pubmed-meshheading:15890415... | lld:pubmed |
pubmed-article:15890415 | pubmed:meshHeading | pubmed-meshheading:15890415... | lld:pubmed |
pubmed-article:15890415 | pubmed:meshHeading | pubmed-meshheading:15890415... | lld:pubmed |
pubmed-article:15890415 | pubmed:meshHeading | pubmed-meshheading:15890415... | lld:pubmed |
pubmed-article:15890415 | pubmed:meshHeading | pubmed-meshheading:15890415... | lld:pubmed |
pubmed-article:15890415 | pubmed:year | 2005 | lld:pubmed |
pubmed-article:15890415 | pubmed:articleTitle | KP-1212/1461, a nucleoside designed for the treatment of HIV by viral mutagenesis. | lld:pubmed |
pubmed-article:15890415 | pubmed:affiliation | Koronis Pharmaceuticals Inc., 12277 134th Ct. N.E. Redmond, WA 98052, USA. kharris@koronispharma.com | lld:pubmed |
pubmed-article:15890415 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15890415 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15890415 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15890415 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15890415 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15890415 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15890415 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15890415 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15890415 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15890415 | lld:pubmed |